DEVELOPMENT, LICENSE AND COMMERCIALIZATION AGREEMENTDevelopment, License and Commercialization Agreement • May 5th, 2014 • Agile Therapeutics Inc • Pharmaceutical preparations • New York
This Development, License and Commercialization Agreement (this “Agreement”) is entered into as of October 18, 2006 (the “Effective Date”) between Corium International, Inc., a Delaware corporation having its principal place of business at 2686 Middlefield Road, Redwood City, CA 94063, (“Corium”), and Agile Therapeutics, Inc., a Delaware corporation, having its principal place of business at 366 Wall Street, Princeton, NJ 08540, (“Agile”).
AGILE THERAPEUTICS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 5th, 2014 • Agile Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT is made as of between Agile Therapeutics, Inc. (the “Company”), a Delaware corporation, and (“Indemnitee”) and shall be effective as of the date hereof.
